IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation
This study has been terminated.
(Principal Investigator left institution; did not complete the study)
Sponsor:
University of Nebraska
Collaborator:
Philips Medical Systems
Information provided by (Responsible Party):
University of Nebraska
ClinicalTrials.gov Identifier:
NCT01007357
First received: October 28, 2009
Last updated: November 12, 2015
Last verified: November 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This project will facilitate the optimization of body MR imaging at 3 Tesla.
| Condition | Intervention |
|---|---|
| Diffuse and Focal Abnormalities of the Liver and Pancreas | Device: Body MR imaging |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation |
Resource links provided by NLM:
Further study details as provided by University of Nebraska:
Primary Outcome Measures:
- to optimize body MR imaging sequences [ Time Frame: 2 years ]
| Enrollment: | 25 |
| Study Start Date: | December 2009 |
| Study Completion Date: | June 2015 |
| Primary Completion Date: | June 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: Body MRI healthy volunteers
Body MRI to optimize sequences in healthy individuals and in disorder subjects
|
Device: Body MR imaging
Body MR imaging will be performed to optimize sequences
Other Name: Body MR imaging performed to optimize sequences
|
Detailed Description:
This project is meant to improve the image quality of multiple sequences at 3.0T applied to the abdominal and pelvic regions.
Eligibility| Ages Eligible for Study: | 19 Years to 65 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Subjects between ages of 19 and 65
- Healthy volunteer subjects should not have any history of disease or symptoms - based on clinical history
- Subjects with an underlying disorder (diffuse and focal abnormalities of the liver and pancreas)
Exclusion Criteria:
- Inability to provide informed consent
- A medical or contraindications that will prevent subjects from having a MRI
- Subjects with severe renal dysfunction or patients on dialysis
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01007357
Please refer to this study by its ClinicalTrials.gov identifier: NCT01007357
Locations
| United States, Nebraska | |
| University of Nebraska Medical Center | |
| Omaha, Nebraska, United States, 68198-1045 | |
| University of Nebraska Medical Center | |
| Omaha, Nebraska, United States, 68198 | |
Sponsors and Collaborators
University of Nebraska
Philips Medical Systems
Investigators
| Principal Investigator: | Shahid Hussain, MD | University of Nebraska |
More Information
| Responsible Party: | University of Nebraska |
| ClinicalTrials.gov Identifier: | NCT01007357 History of Changes |
| Other Study ID Numbers: |
290-09 |
| Study First Received: | October 28, 2009 |
| Last Updated: | November 12, 2015 |
ClinicalTrials.gov processed this record on June 23, 2017